Faes Farma, S.A. (BME:FAE)

Market Cap	1.28B
Revenue (ttm)	510.04M
Net Income (ttm)	111.36M
Shares Out	311.25M
EPS (ttm)	0.36
PE Ratio	11.57
Forward PE	14.46
Dividend	0.16 (3.81%)
Ex-Dividend Date	Jan 9, 2025

Volume	319,852
Average Volume	704,971
Open	4.120
Previous Close	4.120
Day's Range	4.085 - 4.150
52-Week Range	3.260 - 4.160
Beta	0.31
RSI	65.45
Earnings Date	Apr 30, 2025

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 1,775
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.